Cargando…
A Review of T-Cell Related Therapy for Osteosarcoma
Osteosarcoma is one of the most common primary malignant tumors of bone. The combination of chemotherapy and surgery makes the prognosis better than before, but therapy has not dramatically improved over the last three decades. This is partially because of the lack of a novel specialized drug for os...
Autores principales: | Yoshida, Kazushige, Okamoto, Masanori, Aoki, Kaoru, Takahashi, Jun, Saito, Naoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402310/ https://www.ncbi.nlm.nih.gov/pubmed/32664248 http://dx.doi.org/10.3390/ijms21144877 |
Ejemplares similares
-
Antitumor Effect of Sclerostin against Osteosarcoma
por: Ideta, Hirokazu, et al.
Publicado: (2021) -
Clinical outcome of osteosarcoma and its correlation with programmed death-ligand 1 and T cell activation markers
por: Yoshida, Kazushige, et al.
Publicado: (2019) -
Applications of Carbon Nanotubes in Bone Regenerative Medicine
por: Tanaka, Manabu, et al.
Publicado: (2020) -
Physico-Chemical, In Vitro, and In Vivo Evaluation of a 3D Unidirectional Porous Hydroxyapatite Scaffold for Bone Regeneration
por: Tanaka, Manabu, et al.
Publicado: (2017) -
In Vitro and In Vivo Evaluation of a Three-Dimensional Porous Multi-Walled Carbon Nanotube Scaffold for Bone Regeneration
por: Tanaka, Manabu, et al.
Publicado: (2017)